Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

被引:8955
|
作者
Go, AS
Chertow, GM
Fan, DJ
McCulloch, CE
Hsu, CY
机构
[1] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 13期
关键词
D O I
10.1056/NEJMoa041031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.
引用
收藏
页码:1296 / 1305
页数:10
相关论文
共 50 条
  • [41] Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
    Tain, You-Lin
    Hsu, Chien-Ning
    [J]. CHILDREN-BASEL, 2022, 9 (11):
  • [42] Competing Risks of Fracture and Death in Older Adults with Chronic Kidney Disease
    Hall, Rasheeda K.
    Sloane, Richard
    Pieper, Carl
    Van Houtven, Courtney
    LaFleur, Joanne
    Adler, Robert
    Colon-Emeric, Cathleen
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (03) : 532 - 538
  • [43] Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?
    Genovesi, Simonetta
    Gallieni, Maurizio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2014, 13 (09) : 1143 - 1148
  • [44] Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease
    Gerds, Thomas Alexander
    Ravani, Pietro
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2024, 385
  • [45] Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study
    Sarah J. Schrauben
    Christopher Jepson
    Jesse Y. Hsu
    F. Perry Wilson
    Xiaoming Zhang
    James P. Lash
    Bruce M. Robinson
    Raymond R. Townsend
    Jing Chen
    Leon Fogelfeld
    Patricia Kao
    J. Richard Landis
    Daniel J. Rader
    L. Lee Hamm
    Amanda H. Anderson
    Harold I. Feldman
    [J]. BMC Nephrology, 20
  • [46] META-ANALYSIS: STATIN THERAPY TO PREVENT DEATH AND MAJOR CARDIOVASCULAR EVENTS IN PEOPLE WITH CHRONIC KIDNEY DISEASE
    Palmer, Suetonia
    Craig, Jonathan
    Navaneethan, Sankar
    Tonelli, Marcello
    Pellegrini, Fabio
    Strippoli, Giovanni
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 121 - 122
  • [47] Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study
    Schrauben, Sarah J.
    Jepson, Christopher
    Hsu, Jesse Y.
    Wilson, F. Perry
    Zhang, Xiaoming
    Lash, James P.
    Robinson, Bruce M.
    Townsend, Raymond R.
    Chen, Jing
    Fogelfeld, Leon
    Kao, Patricia
    Landis, J. Richard
    Rader, Daniel J.
    Hamm, L. Lee
    Anderson, Amanda H.
    Feldman, Harold I.
    [J]. BMC NEPHROLOGY, 2019, 20 (1)
  • [48] Serum C-Reactive Protein Levels and Death and Cardiovascular Events in Mild to Moderate Chronic Kidney Disease
    Koeda, Yorihiko
    Nakamura, Motoyuki
    Tanaka, Fumitaka
    Onoda, Toshiyuki
    Itai, Kazuyoshi
    Tanno, Kozo
    Ohsawa, Masaki
    Makita, Shinji
    Ishibashi, Yasuhiro
    Koyama, Tomiko
    Yoshida, Yuki
    Omama, Shin-ichi
    Ogasawara, Kuniaki
    Ogawa, Akira
    Kuribayashi, Toru
    Okayama, Akira
    [J]. INTERNATIONAL HEART JOURNAL, 2011, 52 (03) : 180 - 184
  • [49] Hospitalization in chronic kidney disease (CKD).
    Mix, C
    St Peter, WL
    Ebben, J
    Kausz, A
    Xue, J
    Collins, AJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 617A - 618A
  • [50] Sarcopenia predicts cardiovascular disease in chronic kidney disease at advanced stage and associated risks
    Xuan, Yingli
    Pang, Shiqing
    Xie, Weizhen
    He, Ruibin
    Qin, Li
    Yuan, Jiangzi
    [J]. MEDICINE, 2023, 102 (45) : E35976